Incyte’s shares (currently trading at $60.02) have posted a disappointing 11.8% loss while the S&P 500 was down 1.7%. This ...

While many recognize Mia Hamm as a legendary soccer player and two-time Olympic gold medalist, she has also become a ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Shares of Incyte Co. (NASDAQ:INCY – Get Free Report) have been given a consensus recommendation of “Hold” by the nineteen ...

These eight projects took top marks in the three office subcategories for this year's Best Real Estate Deals awards program.

Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® (tafasitamab) by its Mexican affiliate, Grupo ...

The stock's fall snapped a four-day winning streak.